Publications

Parp1 Inhibitor Combined with Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway (Vol 9,719192,2021)

AuthID
P-01A-63S

Author(s)

Li, HF

Wang, CM

Lan, LX

Wu, WH

Evans, I

Ruiz, EJ

Yan, LP

Zhou, ZJ

Oliveira, JM

Reis, RL

Hu, ZR

Chen, W

Behrens, A

He, YL

Zhang, CH

Document Type

Correction

Year published

2025

Published

in FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, ISSN: 2296-634X

Volume: 13

Indexing

Wos^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.3389/fcell.2025.1672461

Pubmed: 40950400

Wos: WOS:001570584800001

Source Identifiers

ISSN: 2296-634X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Parp1 Inhibitor Combined with Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway (Vol 9,719192,2021)

Useful Links

Get Help

Federated Authentication (Click on the image)

Parp1 Inhibitor Combined with Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway (Vol 9,719192,2021)

Useful Links

Get Help